Sedation

8 drugs in development·5 companies·3 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
dexmedetomidine	Mylan II B.V. (MYL)

Phase 3(1)

Drug	Company
melt-300	HARROW, INC. (IMMY)

Phase 2(3)

Drug	Company
melt-210	HARROW, INC. (IMMY)
Propofol Injection	Merus N.V. (MRUS)
Remimazolam Tosilate for injection	Merus N.V. (MRUS)

Unknown(3)

Drug	Company
Ketodex	COGNITION THERAPEUTICS INC (CGTX)
Ketofol	COGNITION THERAPEUTICS INC (CGTX)
remifentanil	GH Research PLC (GHRS)

BioSniper tracks 8 drugs in development for Sedation across 5 companies.

There are 3 clinical trials targeting Sedation tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.